Prospective Database of Factors Associated With Faecal vs. Double Incontinence in Patients Referred for High Resolution Anorectal Manometry.
1 other identifier
observational
150
1 country
1
Brief Summary
This study aims to verify the results from our previous retrospective cohort analysis by establishing a database of well-characterised patients prospectively. The different prevalence of neurological disorders, abdominal, urological and obstetrical surgery, diarrhoea and other potential associated factors as well as the importance of abnormalities identified by 3D high resolution anorectal manometry (HARM) will be compared between subjects with feacal incontinence (FI), double incontinence (DI) and controls. Presence and severity of both FI and urinary incontinence (UI) will be evaluated by disease specific questionnaires. Measuring both disease severity and Quality of Life (QoL) is needed to determine the true impact of incontinence. Finally, the impact on quality of life will be compared between both groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 8, 2022
CompletedFirst Submitted
Initial submission to the registry
August 12, 2022
CompletedFirst Posted
Study publicly available on registry
September 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2030
December 18, 2025
December 1, 2025
5.1 years
August 12, 2022
December 11, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
compose a database of patients suffering from faecal or double incontinence
a database will be created
during inclusion visit
Secondary Outcomes (13)
Confirm the role of diarrhea as a major determinant of double incontinence vs faecal incontinence
during inclusion visit
Confirm the role of diarrhea as a major determinant of double incontinence vs faecal incontinence
during inclusion visit
Confirm the role of diarrhea as a major determinant of double incontinence vs faecal incontinence
during inclusion visit
Confirm the role of diarrhea as a major determinant of double incontinence vs faecal incontinence
during inclusion visit
Confirm the role of diarrhea as a major determinant of double incontinence vs faecal incontinence
during inclusion visit
- +8 more secondary outcomes
Study Arms (3)
Double incontinence
faecal incontinence
controls
Interventions
Eligibility Criteria
All patients referred for HARM for FI are eligible to enroll in the database.
You may qualify if:
- Age \> 18 years;
- Self-reported faecal incontinence.
You may not qualify if:
- Impossibility to perform the anorectal manometry because of pain, stenosis or organic disease;
- Active (peri)rectal inflammation, including abscess;
- Pregnancy;
- Inability to cooperate during the anorectal manometry
- Impossibility to perform HARM due to pain, stenosis or organic disease;
- Inability to complete the questionnaires
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UZ Brussel
Brussels, Brussels Capital, 1090, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2022
First Posted
September 22, 2022
Study Start
June 8, 2022
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
July 1, 2030
Last Updated
December 18, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share